Literature DB >> 5822575

Hemoglobin Philly (beta 35 tyrosine phenylalanine): studies in the molecular pathology of hemoglobin.

R F Rieder, F A Oski, J B Clegg.   

Abstract

An abnormal unstable hemoglobin, hemoglobin Philly, was found in three members of a family, each of whom had evidence of a chronic hemolytic state. The presence of the mutant protein was suggested by the rapid appearance of inclusion bodies upon incubation of erythrocytes with brilliant cresyl blue and by the increased heat precipitability of the hemoglobin. However, no abnormal hemoglobin could be demonstrated by electrophoresis or column chromatography. Sulfhydryl titration of the hemolysates with p-mercuribenzoate indicated that there was an average of four reactive sulfhydryl groups per hemoglobin molecule instead of the usual two. The total number of hemoglobin sulfhydryl groups was normal; six groups were measured when denatured globin was reacted with 5,5'-dithiobis[2-nitrobenzoic acid]. This indicated that the increased sulfhydryl reactivity was due to an increased availability to p-mercuribenzoate of the usually unreactive hemoglobin cysteines at beta112 and alpha104. After treatment for (1/2) hr with 4-5 moles of p-mercuribenzoate per mole of hemoglobin, electrophoresis revealed that 30-35% of the hemoglobin had been dissociated into alpha- and beta-chains. Normal hemolysates revealed negligible splitting after 72 hr of similar treatment. The alpha- and beta-chains of hemoglobin Philly were separated from the unsplit hemoglobin A by carboxymethyl cellulose chromatography. Fingerprint and amino acid analyses revealed that tyrosine beta35 was replaced by phenylalanine. In hemoglobin Philly there is loss of the normal hydrogen bond between the tyrosine hydroxyl group and the carboxyl group of aspartic acid alpha126 at the alpha(1)beta(1) contact. This shifts the equilibrium from hemoglobin tetramers toward monomers, exposing the beta112 and alpha104 cysteines. In the cell, precipitation of the unstable monomers may contribute to erythrocyte destruction.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5822575      PMCID: PMC535734          DOI: 10.1172/JCI106128

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Control of glycolysis in the human red blood cell.

Authors:  I A Rose; J V Warms
Journal:  J Biol Chem       Date:  1966-11-10       Impact factor: 5.157

Review 2.  Destruction of injured red cells in vivo.

Authors:  R A Rifkind
Journal:  Am J Med       Date:  1966-11       Impact factor: 4.965

Review 3.  Hemoglobinopathic dysfunction of the red cell.

Authors:  P Heller
Journal:  Am J Med       Date:  1966-11       Impact factor: 4.965

4.  Haemoglobin Hammersmith (beta-42 (CDI) Phe replaced by ser).

Authors:  J V Dacie; N K Shinton; P J Gaffney; H Lehmann
Journal:  Nature       Date:  1967-11-18       Impact factor: 49.962

5.  Organization of enzymes in human erythrocyte membranes.

Authors:  S L Schrier
Journal:  Am J Physiol       Date:  1966-01

6.  Disulfide-bond cleavage and formation in proteins.

Authors:  O Smithies
Journal:  Science       Date:  1965-12-17       Impact factor: 47.728

7.  Studies on the chemistry of hemoglobin. I. The reactive sulfhydryl groups.

Authors:  G Guidotti
Journal:  J Biol Chem       Date:  1967-08-25       Impact factor: 5.157

8.  On the mechanism of the dissociation of haemoglobin.

Authors:  M A Rosemeyer; E R Huehns
Journal:  J Mol Biol       Date:  1967-04-28       Impact factor: 5.469

9.  Abnormal human haemoglobins. Separation and characterization of the alpha and beta chains by chromatography, and the determination of two new variants, hb Chesapeak and hb J (Bangkok).

Authors:  J B Clegg; M A Naughton; D J Weatherball
Journal:  J Mol Biol       Date:  1966-08       Impact factor: 5.469

10.  Peptide analysis of the inclusions of erythroid cells in beta-thalassemia.

Authors:  P Fessas; D Loukopoulos; A Kaltsoya
Journal:  Biochim Biophys Acta       Date:  1966-08-24
View more
  10 in total

1.  Heterogeneity of the hemoglobin of the Ohrid trout (Salmo L. typicus).

Authors:  B Cepreganova; J B Wilson; B B Webber; B Kjovkareska; G D Efremov; T H Huisman
Journal:  Biochem Genet       Date:  1992-08       Impact factor: 1.890

2.  The structure of α-haemoglobin in complex with a haemoglobin-binding domain from Staphylococcus aureus reveals the elusive α-haemoglobin dimerization interface.

Authors:  Kaavya Krishna Kumar; David A Jacques; J Mitchell Guss; David A Gell
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-07-23       Impact factor: 1.056

3.  An unstable haemoglobin, Hb Tacoma beta30 (B12) arg leads to ser, detected at birth by the demonstration of red cell inclusions.

Authors:  R A Deacon-Smith; J P Lee-Potter
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

4.  Site-directed mutations of human hemoglobin at residue 35beta: a residue at the intersection of the alpha1beta1, alpha1beta2, and alpha1alpha2 interfaces.

Authors:  J S Kavanaugh; J A Weydert; P H Rogers; A Arnone; H L Hui; A M Wierzba; L D Kwiatkowski; P Paily; R W Noble; S Bruno; A Mozzarelli
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

Review 5.  Hemoglobin variants: biochemical properties and clinical correlates.

Authors:  Christopher S Thom; Claire F Dickson; David A Gell; Mitchell J Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

6.  The role of hemoglobin heme loss in Heinz body formation: studies with a partially heme-deficient hemoglobin and with genetically unstable hemoglobins.

Authors:  H S Jacob; K H Winterhalter
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

7.  Hemoglobin Abraham Lincoln, beta32 (B14) leucine leads to proline. An unstable variant producing severe hemolytic disease.

Authors:  G R Honig; D Green; M Shamsuddin; L N Vida; R G Mason; D J Gnarra; H S Maurer
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

8.  Hemoglobin stability: observations on the denaturation of normal and abnormal hemoglobins by oxidant dyes, heat, and alkali.

Authors:  R F Rieder
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

9.  Hemoglobin Louisville (beta-42 (CD1) phe-leu): an unstable variant causing mild hemolytic anemia.

Authors:  M M Keeling; L L Ogden; R N Wrightstone; J B Wilson; C A Reynolds; J L Kitchens; T H Huisman
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808

10.  Hemoglobin Savannah (B6(24) beta-glycine is greater than valine): an unstable variant causing anemia with inclusion bodies.

Authors:  T H Huisman; A K Brown; G D Efremov; J B Wilson; C A Reynolds; R Uy; L L Smith
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.